Industry Hails Access Implications As FTC Promises PBM Probe
Follows AAM And Biosimilars Forum’s Calls For Action Over Behaviors That Restrict Access
• By David Wallace
Industry is hoping the inquiry could help unlock access to generics and biosimilars • Source: Shutterstock 
